MINK THERAPEUTICS INC's ticker is and the CUSIP is 603693102. A total of 17 filers reported holding MINK THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $105,517 | -45.8% | 90,164 | -2.8% | 0.00% | – |
| Q2 2023 | $194,718 | +300.9% | 92,723 | +266.6% | 0.00% | – |
| Q1 2023 | $48,566 | +74616.9% | 25,295 | 0.0% | 0.00% | – |
| Q4 2022 | $65 | -99.9% | 25,295 | +9.1% | 0.00% | – |
| Q3 2022 | $48,000 | +50.0% | 23,175 | 0.0% | 0.00% | – |
| Q2 2022 | $32,000 | -57.9% | 23,175 | -31.6% | 0.00% | – |
| Q1 2022 | $76,000 | -27.6% | 33,904 | +43.8% | 0.00% | – |
| Q4 2021 | $105,000 | – | 23,575 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sofinnova Investments, Inc. | 345,499 | $1,541,000 | 0.09% |
| Artal Group S.A. | 289,588 | $1,292,000 | 0.04% |
| Gyon Technologies Capital Management, LP | 42,448 | $189,000 | 0.04% |
| RTW INVESTMENTS, LP | 416,666 | $1,858,000 | 0.03% |
| VANGUARD GROUP INC | 10,771 | $48,000 | 0.00% |
| Ameritas Investment Partners, Inc. | 150 | $1,000 | 0.00% |
| UBS Group AG | 3,934 | $18,000 | 0.00% |
| AMERICAN INTERNATIONAL GROUP, INC. | 1,037 | $5,000 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 1,847 | $8,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 1,207 | $5,000 | 0.00% |